BindingDB logo
myBDB logout

PubMed code 23415088

Compile data set for download or QSAR
Found 4 hits of Enzyme Inhibition Constant Data   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kJ/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
cAMP-specific 3',5'-cyclic phosphodiesterase 4B


(Homo sapiens (Human))
BDBM50430301
PNG
(CHEMBL2333447)
Show SMILES NS(=O)(=O)c1cc2nc(-c3cc(Br)ccc3F)n3c2c(c1)oc1ccccc31
Show InChI InChI=1S/C19H11BrFN3O3S/c20-10-5-6-13(21)12(7-10)19-23-14-8-11(28(22,25)26)9-17-18(14)24(19)15-3-1-2-4-16(15)27-17/h1-9H,(H2,22,25,26)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 530n/an/an/an/an/an/a



Medicinal Chemistry Laboratory, Research Centre, CKM Arts and Science College, Warangal 506 006, Andhra Pradesh, India.

Curated by ChEMBL


Assay Description
Inhibition of PDE4B1 (unknown origin) expressed in sf9 cells using cAMP as substrate preincubated for 15 mins before substrate addition measured afte...


Bioorg Med Chem 21: 1952-63 (2013)


Article DOI: 10.1016/j.bmc.2013.01.023
BindingDB Entry DOI: 10.7270/Q22Z16VZ
More data for this
Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4B


(Homo sapiens (Human))
BDBM14361
PNG
((R,S)-Rolipram | 4-(3-cyclopentyloxy-4-methoxy-phe...)
Show SMILES COc1ccc(cc1OC1CCCC1)C1CNC(=O)C1
Show InChI InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
Purchase

CHEMBL
MCE
PC cid
PC sid
PDB
UniChem

Patents


Similars

PDB
Article
PubMed
n/an/a 941n/an/an/an/an/an/a



Medicinal Chemistry Laboratory, Research Centre, CKM Arts and Science College, Warangal 506 006, Andhra Pradesh, India.

Curated by ChEMBL


Assay Description
Inhibition of PDE4B1 (unknown origin) expressed in sf9 cells using cAMP as substrate preincubated for 15 mins before substrate addition measured afte...


Bioorg Med Chem 21: 1952-63 (2013)


Article DOI: 10.1016/j.bmc.2013.01.023
BindingDB Entry DOI: 10.7270/Q22Z16VZ
More data for this
Ligand-Target Pair
3D
3D Structure (crystal)
cAMP-specific 3',5'-cyclic phosphodiesterase 4B


(Homo sapiens (Human))
BDBM50430302
PNG
(CHEMBL2333459)
Show SMILES NS(=O)(=O)c1cc2nc(-c3cccc(Br)c3)n3c2c(c1)oc1ccccc31
Show InChI InChI=1S/C19H12BrN3O3S/c20-12-5-3-4-11(8-12)19-22-14-9-13(27(21,24)25)10-17-18(14)23(19)15-6-1-2-7-16(15)26-17/h1-10H,(H2,21,24,25)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 1.23E+3n/an/an/an/an/an/a



Medicinal Chemistry Laboratory, Research Centre, CKM Arts and Science College, Warangal 506 006, Andhra Pradesh, India.

Curated by ChEMBL


Assay Description
Inhibition of PDE4B1 (unknown origin) expressed in sf9 cells using cAMP as substrate preincubated for 15 mins before substrate addition measured afte...


Bioorg Med Chem 21: 1952-63 (2013)


Article DOI: 10.1016/j.bmc.2013.01.023
BindingDB Entry DOI: 10.7270/Q22Z16VZ
More data for this
Ligand-Target Pair
cAMP-specific 3',5'-cyclic phosphodiesterase 4B


(Homo sapiens (Human))
BDBM50430303
PNG
(CHEMBL2333455)
Show SMILES NS(=O)(=O)c1cc2nc(-c3ccccc3O)n3c2c(c1)oc1ccccc31
Show InChI InChI=1S/C19H13N3O4S/c20-27(24,25)11-9-13-18-17(10-11)26-16-8-4-2-6-14(16)22(18)19(21-13)12-5-1-3-7-15(12)23/h1-10,23H,(H2,20,24,25)
PDB

UniProtKB/SwissProt

antibodypedia
GoogleScholar
AffyNet 
CHEMBL
PC cid
PC sid
UniChem

Similars

Article
PubMed
n/an/a 3.31E+3n/an/an/an/an/an/a



Medicinal Chemistry Laboratory, Research Centre, CKM Arts and Science College, Warangal 506 006, Andhra Pradesh, India.

Curated by ChEMBL


Assay Description
Inhibition of PDE4B1 (unknown origin) expressed in sf9 cells using cAMP as substrate preincubated for 15 mins before substrate addition measured afte...


Bioorg Med Chem 21: 1952-63 (2013)


Article DOI: 10.1016/j.bmc.2013.01.023
BindingDB Entry DOI: 10.7270/Q22Z16VZ
More data for this
Ligand-Target Pair
* indicates data uncertainty>20%